Unichem Laboratories, 506690, UNICHEMLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,819.64
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,769.86
1.55%
0.72

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

3.92
-1.90
-4.27

EBITDA CAGR (%)

10 Years
5 Years
3 Years

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

21.40
24.43
-

P:BV (Average)

8 Years
5 Years
3 Years

0.46
0.46
0.46

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.25
23.23
28.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 240.77 232.52 3.55% 216.07 277.08 -22.02% 231.19 244.36 -5.39% 225.10 244.94 -8.10%
Expenses 248.58 250.64 -0.82% 227.05 281.89 -19.45% 256.90 263.72 -2.59% 260.92 243.10 7.33%
EBITDA -7.81 -18.12 - -10.98 -4.81 - -25.70 -19.35 - -35.82 1.84 -
EBIDTM -3.24% -7.79% -5.08% -1.73% -11.12% -7.92% -15.91% 0.75%
Other Income 18.73 27.98 -33.06% 19.13 22.56 -15.20% 23.01 27.29 -15.68% 29.05 32.56 -10.78%
Interest 0.16 0.05 220.00% 0.59 0.41 43.90% 0.42 0.13 223.08% 0.23 0.07 228.57%
Depreciation 18.31 16.86 8.60% 19.11 17.72 7.84% 17.26 16.83 2.55% 17.86 14.81 20.59%
PBT -7.55 -7.03 - -11.54 -0.38 - -20.37 -9.02 - -24.86 19.52 -
Tax 0.00 -7.50 - 0.00 -4.08 - 0.00 -15.34 - 0.00 1.84 -100.00%
PAT -7.55 0.46 - -11.55 3.69 - -20.37 6.32 - -24.86 17.68 -
PATM -3.13% 0.20% -5.34% 1.33% -8.81% 2.59% -11.05% 7.22%
EPS -1.07 0.07 - -1.64 0.52 - -2.89 0.90 - -3.53 2.51 -

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 317.27 297.74 6.56% 320.23 374.24 -14.43% 0.00 0.00 0 295.61 261.15 13.20%
Expenses 305.19 317.95 -4.01% 306.87 350.81 -12.53% 0.00 0.00 0 322.41 315.12 2.31%
EBITDA 12.08 -20.22 - 13.36 23.44 -43.00% 0.00 0.00 0 -26.81 -53.97 -
EBIDTM 3.81% -6.79% 4.17% 6.26% 0.00% 0.00% -9.07% -20.66%
Other Income 16.71 26.26 -36.37% 11.82 20.71 -42.93% 0.00 0.00 0 28.13 31.64 -11.09%
Interest 1.25 1.28 -2.34% 2.40 2.84 -15.49% 0.00 0.00 0 1.86 1.35 37.78%
Depreciation 20.54 18.25 12.55% 22.96 18.51 24.04% 0.00 0.00 0 20.98 16.06 30.64%
PBT 7.00 -13.49 - -0.17 22.80 - 0.00 0.00 0 -21.51 -39.73 -
Tax 4.61 -7.53 - 17.63 -9.01 - 0.00 0.00 0 0.68 -1.75 -
PAT 2.39 -5.96 - -17.80 31.82 - 0.00 0.00 0 -22.19 -37.98 -
PATM 0.75% -2.00% -5.56% 8.50% 0.00% 0.00% -7.51% -14.55%
EPS 0.34 -0.85 - -2.53 4.52 - 0.00 0.00 0 -3.15 -5.40 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 913.13 904.89 975.88 1,231.38 1,418.41 1,220.52 1,090.98 1,044.17 1,005.22 803.19 764.74 Net Sales Growth -8.59% -7.27% -20.75% -13.19% 16.21% 11.87% 4.48% 3.87% 25.15% 5.03% Cost Of Goods Sold 391.94 311.23 339.36 274.57 188.07 395.62 375.39 327.82 335.81 263.68 226.54 Gross Profit 521.19 593.66 636.52 956.81 1,230.34 824.90 715.59 716.36 669.41 539.51 538.20 GP Margin 57.08% 65.61% 65.23% 77.70% 86.74% 67.59% 65.59% 68.61% 66.59% 67.17% 70.38% Total Expenditure 993.45 995.50 1,034.20 1,214.03 1,252.60 1,078.24 989.74 863.16 823.08 678.06 603.35 Power & Fuel Cost - 72.14 75.43 48.26 40.76 37.34 38.36 34.96 30.55 25.45 21.83 % Of Sales - 7.97% 7.73% 3.92% 2.87% 3.06% 3.52% 3.35% 3.04% 3.17% 2.85% Employee Cost - 205.16 177.56 146.54 117.68 209.60 178.04 147.14 128.01 104.88 93.07 % Of Sales - 22.67% 18.19% 11.90% 8.30% 17.17% 16.32% 14.09% 12.73% 13.06% 12.17% Manufacturing Exp. - 139.62 125.44 115.50 90.53 132.41 129.61 121.78 106.97 91.99 90.39 % Of Sales - 15.43% 12.85% 9.38% 6.38% 10.85% 11.88% 11.66% 10.64% 11.45% 11.82% General & Admin Exp. - 196.56 209.96 566.05 722.03 145.52 132.64 108.27 84.16 72.03 65.49 % Of Sales - 21.72% 21.51% 45.97% 50.90% 11.92% 12.16% 10.37% 8.37% 8.97% 8.56% Selling & Distn. Exp. - 66.88 87.17 52.96 65.40 132.40 127.44 120.75 125.03 110.10 104.08 % Of Sales - 7.39% 8.93% 4.30% 4.61% 10.85% 11.68% 11.56% 12.44% 13.71% 13.61% Miscellaneous Exp. - 3.91 19.29 10.15 28.13 25.35 8.26 2.44 12.55 9.92 104.08 % Of Sales - 0.43% 1.98% 0.82% 1.98% 2.08% 0.76% 0.23% 1.25% 1.24% 0.25% EBITDA -80.31 -90.61 -58.32 17.35 165.81 142.28 101.24 181.01 182.14 125.13 161.39 EBITDA Margin -8.80% -10.01% -5.98% 1.41% 11.69% 11.66% 9.28% 17.34% 18.12% 15.58% 21.10% Other Income 89.92 99.17 101.54 3,280.20 7.19 22.71 20.31 42.96 17.61 11.69 7.96 Interest 1.40 1.28 0.62 3.17 2.00 2.29 2.37 2.48 2.48 3.30 1.95 Depreciation 72.54 71.09 61.71 45.04 39.41 34.99 37.68 42.67 34.82 28.29 27.22 PBT -64.32 -63.81 -19.11 3,249.34 131.60 127.70 81.50 178.82 162.45 105.24 140.18 Tax 0.00 -7.50 -27.91 692.74 27.73 23.69 17.10 43.00 32.85 22.77 31.68 Tax Rate 0.00% 11.75% 146.05% 21.32% 21.07% 19.08% 20.98% 24.05% 20.22% 21.64% 22.60% PAT -64.33 -56.32 8.80 2,556.60 103.87 100.48 64.40 135.82 129.60 82.46 108.50 PAT before Minority Interest -64.33 -56.32 8.80 2,556.60 103.87 100.48 64.40 135.82 129.60 82.46 108.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -7.04% -6.22% 0.90% 207.62% 7.32% 8.23% 5.90% 13.01% 12.89% 10.27% 14.19% PAT Growth -328.53% - -99.66% 2,361.35% 3.37% 56.02% -52.58% 4.80% 57.17% -24.00% EPS -9.14 -8.00 1.25 363.15 14.75 14.27 9.15 19.29 18.41 11.71 15.41

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales - 1,210.62 1,188.19 1,379.90 1,540.06 1,332.65 1,201.79 1,133.45 1,080.80 875.46 824.04 Net Sales Growth - 1.89% -13.89% -10.40% 15.56% 10.89% 6.03% 4.87% 23.46% 6.24% Cost Of Goods Sold - 308.19 364.19 274.97 188.77 386.97 378.57 332.84 343.06 278.55 237.98 Gross Profit - 902.43 823.99 1,104.93 1,351.28 945.67 823.23 800.61 737.75 596.91 586.07 GP Margin - 74.54% 69.35% 80.07% 87.74% 70.96% 68.50% 70.63% 68.26% 68.18% 71.12% Total Expenditure - 1,261.44 1,269.21 1,358.21 1,357.62 1,168.77 1,100.79 955.75 910.06 759.42 674.08 Power & Fuel Cost - 73.02 76.39 49.23 41.62 38.25 39.39 35.97 31.36 26.22 22.50 % Of Sales - 6.03% 6.43% 3.57% 2.70% 2.87% 3.28% 3.17% 2.90% 2.99% 2.73% Employee Cost - 273.28 239.32 200.64 169.04 255.92 223.20 187.37 164.88 140.06 123.99 % Of Sales - 22.57% 20.14% 14.54% 10.98% 19.20% 18.57% 16.53% 15.26% 16.00% 15.05% Manufacturing Exp. - 151.01 136.15 125.30 103.70 150.54 145.03 137.05 119.15 101.54 102.67 % Of Sales - 12.47% 11.46% 9.08% 6.73% 11.30% 12.07% 12.09% 11.02% 11.60% 12.46% General & Admin Exp. - 228.99 239.66 594.53 744.66 167.66 153.29 127.77 104.73 88.54 79.74 % Of Sales - 18.92% 20.17% 43.09% 48.35% 12.58% 12.76% 11.27% 9.69% 10.11% 9.68% Selling & Distn. Exp. - 223.02 197.24 108.38 107.77 166.84 157.12 134.03 135.93 116.00 106.52 % Of Sales - 18.42% 16.60% 7.85% 7.00% 12.52% 13.07% 11.82% 12.58% 13.25% 12.93% Miscellaneous Exp. - 3.93 16.26 5.16 2.06 2.58 4.19 0.73 10.97 8.50 106.52 % Of Sales - 0.32% 1.37% 0.37% 0.13% 0.19% 0.35% 0.06% 1.01% 0.97% 0.08% EBITDA - -50.82 -81.02 21.69 182.44 163.88 101.00 177.70 170.74 116.04 149.96 EBITDA Margin - -4.20% -6.82% 1.57% 11.85% 12.30% 8.40% 15.68% 15.80% 13.25% 18.20% Other Income - 91.31 98.41 3,278.19 5.50 19.11 20.72 42.38 16.96 12.50 8.32 Interest - 7.85 7.52 8.01 3.36 2.90 3.04 3.19 3.29 4.08 2.39 Depreciation - 81.67 67.37 50.51 43.52 38.79 41.27 45.72 38.34 30.43 29.22 PBT - -49.02 -57.50 3,241.36 141.07 141.31 77.41 171.17 146.07 94.03 126.66 Tax - 11.97 -33.64 696.23 32.58 29.30 2.13 43.00 32.85 22.77 31.68 Tax Rate - -24.42% 58.50% 21.48% 23.09% 21.27% 2.75% 25.12% 22.49% 24.22% 25.01% PAT - -61.00 -23.87 2,545.13 108.49 108.48 75.28 128.16 113.23 71.26 94.98 PAT before Minority Interest - -61.00 -23.87 2,545.13 108.49 108.48 75.28 128.16 113.23 71.26 94.98 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - -5.04% -2.01% 184.44% 7.04% 8.14% 6.26% 11.31% 10.48% 8.14% 11.53% PAT Growth - - - 2,245.96% 0.01% 44.10% -41.26% 13.19% 58.90% -24.97% EPS - -8.66 -3.39 361.52 15.41 15.41 10.69 18.20 16.08 10.12 13.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 2,647.18 2,731.93 2,761.67 1,130.73 1,027.15 947.42 906.27 812.95 730.05 678.02 Share Capital 14.08 14.08 14.07 18.18 18.17 18.15 18.13 18.09 18.06 18.05 Total Reserves 2,628.28 2,714.02 2,747.01 1,111.11 1,007.83 928.41 887.39 793.86 711.27 659.17 Non-Current Liabilities 29.68 26.79 50.07 70.40 63.66 69.27 73.08 73.42 72.20 68.43 Secured Loans 0.00 0.00 0.33 0.44 0.46 0.22 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.49 22.72 Long Term Provisions 23.51 14.60 10.76 25.33 12.58 8.88 7.64 9.19 10.24 7.90 Current Liabilities 348.27 271.50 295.88 301.81 282.61 205.00 227.27 246.34 224.19 169.20 Trade Payables 208.22 192.69 211.51 228.28 189.63 142.63 151.13 159.09 136.78 106.92 Other Current Liabilities 115.02 67.56 60.40 56.73 47.43 36.32 29.71 29.87 29.23 22.69 Short Term Borrowings 15.21 0.00 0.00 0.55 7.90 0.00 0.63 5.72 24.87 8.47 Short Term Provisions 9.81 11.25 23.97 16.25 37.65 26.05 45.80 51.67 33.30 31.13 Total Liabilities 3,025.13 3,030.22 3,107.62 1,502.94 1,373.42 1,221.69 1,206.62 1,132.71 1,026.44 915.65 Net Block 824.94 785.16 551.12 464.17 381.20 395.87 393.72 426.22 385.21 355.64 Gross Block 1,037.52 939.38 655.08 535.64 414.65 683.53 642.30 637.46 562.43 504.43 Accumulated Depreciation 212.58 154.22 103.96 71.47 33.45 287.67 248.58 211.24 177.22 148.78 Non Current Assets 1,520.42 1,177.12 895.56 815.69 744.42 676.73 642.69 671.09 614.20 513.66 Capital Work in Progress 330.84 90.25 235.53 247.26 232.65 118.66 86.31 129.29 111.34 62.87 Non Current Investment 252.77 245.36 86.97 85.16 102.52 117.61 114.25 107.20 91.62 78.85 Long Term Loans & Adv. 111.88 56.36 21.94 19.11 28.05 44.59 48.42 8.38 26.02 16.29 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,504.71 1,853.10 2,212.05 687.25 629.00 544.95 563.92 461.63 412.25 402.00 Current Investments 419.10 800.75 895.55 8.00 8.04 35.04 5.67 33.06 14.50 21.29 Inventories 315.57 274.18 207.76 253.98 200.66 186.48 186.24 131.63 141.13 135.42 Sundry Debtors 323.10 331.35 231.74 296.49 264.73 206.19 211.28 212.28 184.82 183.94 Cash & Bank 205.37 191.03 673.61 10.16 10.94 19.71 40.83 16.66 13.86 10.44 Other Current Assets 241.57 63.63 57.89 18.21 144.63 97.52 119.92 68.00 57.93 50.91 Short Term Loans & Adv. 182.77 192.16 145.51 100.40 121.55 80.97 103.50 59.71 51.11 45.60 Net Current Assets 1,156.45 1,581.60 1,916.17 385.44 346.38 339.96 336.65 215.28 188.06 232.79 Total Assets 3,025.13 3,030.22 3,107.61 1,502.94 1,373.42 1,221.68 1,206.61 1,132.72 1,026.45 915.66

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 2,531.35 2,619.91 2,680.08 1,063.62 954.33 867.52 816.61 727.07 660.58 617.70 Share Capital 14.08 14.08 14.07 18.18 18.17 18.15 18.13 18.09 18.06 18.05 Total Reserves 2,512.44 2,601.99 2,665.42 1,044.00 935.01 848.52 797.74 707.98 641.80 598.85 Non-Current Liabilities 43.72 10.10 46.46 64.49 76.02 74.21 97.72 94.31 92.67 87.44 Secured Loans 0.00 0.00 0.33 0.44 22.98 20.35 24.65 20.89 20.47 19.01 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.49 22.72 Long Term Provisions 23.51 14.60 10.76 25.33 12.58 8.88 7.64 9.19 10.24 7.90 Current Liabilities 566.73 502.92 463.51 392.62 275.09 211.76 230.32 251.12 233.30 176.15 Trade Payables 250.22 221.41 226.23 210.73 163.95 138.23 150.52 156.63 140.30 109.99 Other Current Liabilities 122.04 68.45 63.03 68.01 60.56 45.86 32.99 36.65 34.28 26.00 Short Term Borrowings 184.03 199.67 150.29 97.62 12.93 1.63 1.04 6.17 25.42 9.04 Short Term Provisions 10.44 13.39 23.97 16.25 37.65 26.05 45.78 51.67 33.30 31.13 Total Liabilities 3,141.80 3,132.93 3,190.05 1,520.73 1,305.44 1,153.49 1,144.65 1,072.50 986.55 881.29 Net Block 866.06 806.29 574.45 487.22 402.60 415.99 419.29 447.76 408.39 377.31 Gross Block 1,103.64 975.96 689.74 561.37 439.53 724.65 688.25 675.87 599.27 537.04 Accumulated Depreciation 237.59 169.67 115.29 74.15 36.92 308.66 268.96 228.11 190.87 159.73 Non Current Assets 1,455.33 1,093.64 853.59 772.27 673.34 589.07 563.97 594.06 547.20 456.50 Capital Work in Progress 330.47 92.39 238.15 249.98 237.13 122.64 90.54 132.20 112.76 62.87 Non Current Investment 134.38 129.20 9.20 9.51 5.54 5.83 5.72 5.72 0.03 0.03 Long Term Loans & Adv. 112.90 56.37 24.05 25.57 28.05 44.61 48.42 8.38 26.02 16.29 Other Non Current Assets 11.52 9.39 7.74 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,686.47 2,039.29 2,336.47 748.46 632.11 564.42 580.68 478.44 439.35 424.79 Current Investments 419.10 800.75 895.55 8.00 8.04 35.04 5.67 33.06 14.50 21.29 Inventories 396.54 338.66 272.86 281.71 230.57 207.68 203.49 143.05 157.96 150.26 Sundry Debtors 390.14 436.05 276.92 315.32 220.09 191.58 196.51 206.95 183.25 185.13 Cash & Bank 233.81 200.99 681.46 16.14 20.13 26.96 52.15 24.64 23.23 15.16 Other Current Assets 246.88 68.65 64.17 28.49 153.28 103.17 122.86 70.75 60.40 52.95 Short Term Loans & Adv. 183.04 194.18 145.51 98.80 122.77 82.25 105.67 61.73 53.14 47.14 Net Current Assets 1,119.74 1,536.37 1,872.95 355.84 357.02 352.66 350.36 227.32 206.05 248.65 Total Assets 3,141.80 3,132.93 3,190.06 1,520.73 1,305.45 1,153.49 1,144.65 1,072.50 986.55 881.29

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -41.84 -251.30 -66.25 140.78 116.58 88.03 86.87 180.30 129.26 80.60 PBT -63.81 -19.11 3,249.34 131.60 124.17 81.50 178.82 162.45 105.24 140.18 Adjustment -6.17 -7.08 -3,214.36 72.37 56.10 36.30 20.38 46.82 37.81 26.45 Changes in Working Capital 25.49 -217.91 -103.24 -35.89 -32.73 -11.59 -74.94 5.77 8.92 -55.28 Cash after chg. in Working capital -44.49 -244.10 -68.27 168.08 147.55 106.21 124.26 215.04 151.97 111.35 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 2.65 -7.20 2.01 -27.30 -30.97 -18.17 -37.39 -34.74 -22.71 -30.75 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -35.59 -322.63 1,648.30 -131.91 -86.73 -62.18 35.22 -126.60 -110.97 -53.44 Net Fixed Assets -338.73 -139.02 -107.71 -135.60 154.89 -73.58 38.14 -92.98 -106.47 -67.03 Net Investments 374.24 -63.59 -889.36 17.40 42.09 -32.73 20.34 -34.14 -5.98 28.17 Others -71.10 -120.02 2,645.37 -13.71 -283.71 44.13 -23.26 0.52 1.48 -14.58 Cash from Financing Activity -21.02 -44.89 -929.51 -8.95 -38.63 -46.97 -97.92 -50.90 -14.87 -35.78 Net Cash Inflow / Outflow -98.45 -618.82 652.53 -0.08 -8.77 -21.12 24.17 2.80 3.42 -8.62 Opening Cash & Equivalents 188.66 660.31 7.77 7.86 19.71 40.83 16.66 13.86 10.44 19.06 Closing Cash & Equivalent 203.08 188.66 660.31 7.77 10.94 19.71 40.83 16.66 13.86 10.44

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 19.82 -327.77 -112.34 68.19 111.91 78.10 86.73 171.23 124.08 68.59 PBT -48.21 -57.44 3,241.14 141.25 137.68 77.41 171.17 146.07 94.03 126.66 Adjustment 18.79 6.80 -3,207.66 53.31 39.65 35.57 18.74 47.15 39.37 27.54 Changes in Working Capital 53.58 -264.94 -146.67 -98.65 -34.16 -16.49 -66.32 13.05 13.51 -54.81 Cash after chg. in Working capital 24.15 -315.57 -113.20 95.91 143.16 96.49 123.58 206.27 146.91 99.39 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.34 -12.20 0.86 -27.72 -31.25 -18.39 -36.85 -35.04 -22.83 -30.81 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -41.21 -286.01 1,648.33 -127.87 -85.33 -52.34 35.70 -118.45 -101.80 -47.60 Net Fixed Assets -338.73 -139.02 -107.71 -135.60 154.89 -73.58 38.14 -92.98 -106.47 -67.03 Net Investments 374.24 -63.59 -889.36 17.40 42.09 -32.73 20.34 -34.14 -5.98 28.17 Others -76.72 -83.40 2,645.40 -9.67 -282.31 53.97 -22.78 8.67 10.65 -8.74 Cash from Financing Activity -62.30 -2.42 -881.13 59.23 -33.42 -50.95 -94.92 -51.38 -14.21 -29.46 Net Cash Inflow / Outflow -83.69 -616.19 654.86 -0.46 -6.84 -25.19 27.51 1.41 8.07 -8.48 Opening Cash & Equivalents 197.05 666.07 11.21 11.67 26.96 52.15 24.64 23.23 15.16 23.64 Closing Cash & Equivalent 226.22 197.05 666.07 11.21 20.13 26.96 52.15 24.64 23.23 15.16

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 375.30 387.60 392.55 124.27 112.94 104.28 99.92 89.76 80.75 75.05 ROA -1.86% 0.29% 110.90% 7.22% 7.74% 5.30% 11.61% 12.00% 8.49% 12.44% ROE -2.10% 0.32% 131.43% 9.64% 10.19% 6.95% 15.82% 16.82% 11.73% 16.86% ROCE -2.32% -0.67% 167.06% 12.33% 12.75% 9.04% 21.01% 20.65% 14.59% 21.17% Fixed Asset Turnover 0.92 1.22 2.07 2.99 2.25 1.66 1.64 1.69 1.52 1.64 Receivable days 131.99 105.30 78.26 72.16 69.53 69.33 73.49 71.54 83.25 82.07 Inventory Days 118.94 90.13 68.41 58.46 57.16 61.90 55.15 49.14 62.43 55.22 Payable days 82.50 83.55 118.77 140.05 63.62 59.84 69.69 71.38 71.47 69.28 Cash Conversion Cycle 168.43 111.88 27.91 -9.43 63.06 71.39 58.95 49.31 74.22 68.01 Total Debt/Equity 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.07 0.05 Interest Cover -48.78 -29.97 1027.03 66.88 55.19 35.41 73.06 66.46 32.90 72.95

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 358.85 371.69 380.95 116.88 104.93 95.48 90.02 80.27 73.06 68.36 ROA -1.94% -0.75% 108.06% 7.68% 8.82% 6.55% 11.56% 11.00% 7.63% 11.31% ROE -2.37% -0.90% 136.04% 10.77% 11.92% 8.95% 16.62% 16.34% 11.16% 16.11% ROCE -1.49% -1.77% 162.77% 13.42% 14.97% 9.29% 21.84% 20.13% 14.03% 20.37% Fixed Asset Turnover 1.16 1.43 2.21 3.08 2.32 1.71 1.67 1.71 1.55 1.66 Receivable days 124.55 109.51 78.30 63.41 55.72 58.55 64.53 65.42 76.34 77.46 Inventory Days 110.83 93.93 73.33 60.67 59.32 62.03 55.42 50.47 63.88 56.72 Payable days 74.71 74.09 94.97 104.25 52.00 52.61 62.52 65.77 65.64 63.82 Cash Conversion Cycle 160.67 129.34 56.65 19.82 63.05 67.97 57.43 50.11 74.58 70.36 Total Debt/Equity 0.07 0.08 0.06 0.09 0.04 0.03 0.03 0.04 0.11 0.08 Interest Cover -5.25 -6.64 405.79 43.00 48.57 26.45 54.66 45.40 24.06 53.94

Top Investors:

hdfc small cap fund

krishnaraj venkataraman

iepf

Annual Reports:

News Update:

Unichem Laboratories calls for measures to step up local production of raw materials
10th Aug 2020, 14:07 PM

The ongoing coronavirus pandemic calls for concentrated efforts to build upon capacities for active pharmaceutical ingredients in the country
Read More
Unichem Laboratories gets ANDA's approval for Tolterodine Tartrate tablets
6th Aug 2020, 14:24 PM

The product will be commercialized from Unichem’s Goa plant
Read More
Unichem Laboratories turns black in Q1
5th Aug 2020, 10:18 AM

Total income of the company increased by 11.52% at Rs 333.98 crore for Q1FY21
Read More
Unichem Lab - Quarterly Results
4th Aug 2020, 16:47 PM

Read More
Unichem Laboratories receives ANDA approval for Amiodarone Tablets
22nd Jul 2020, 13:06 PM

The product will be commercialized from Unichem’s Ghaziabad Plant
Read More
Unichem Lab secures ANDA's nod for Baclofen Tablets
10th Jul 2020, 14:35 PM

Baclofen Tablets are indicated for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis
Read More
Unichem Lab secures ANDA's nod for Cyclobenzaprine Hydrochloride Tablets
7th Jul 2020, 14:52 PM

Cyclobenzaprine HCI Tablets are indicated for the treatment as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions
Read More

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506690 | NSE: UNICHEMLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506690 | NSE: UNICHEMLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: